Search Results

D-Pantothenic acid 100 mg  | 99.63%

TargetMol

D-Pantothenic Acid is a water-soluble vitamin ubiquitously found in plants and animal tissues with an antioxidant property. Vitamin B5 is a component of coenzyme A (CoA) and a part of the vitamin B2 complex. Vitamin B5 is a growth factor and is essential for various metabolic functions, including the metabolism of carbohydrates, proteins, and fatty […]

More Information Supplier Page

D-Pantothenic acid 200 mg  | 99.63%

TargetMol

D-Pantothenic Acid is a water-soluble vitamin ubiquitously found in plants and animal tissues with an antioxidant property. Vitamin B5 is a component of coenzyme A (CoA) and a part of the vitamin B2 complex. Vitamin B5 is a growth factor and is essential for various metabolic functions, including the metabolism of carbohydrates, proteins, and fatty […]

More Information Supplier Page

Astragaloside A 25 mg  | 99.87%

TargetMol

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the therapy of cardiovascular diseases.

More Information Supplier Page

Astragaloside A 10 mg  | 99.87%

TargetMol

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the therapy of cardiovascular diseases.

More Information Supplier Page

Copanlisib 5 mg  | 99.88%

TargetMol

Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor […]

More Information Supplier Page

Copanlisib 50 mg  | 99.88%

TargetMol

Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor […]

More Information Supplier Page

Copanlisib 2 mg  | 99.88%

TargetMol

Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor […]

More Information Supplier Page

Copanlisib 10 mg  | 99.88%

TargetMol

Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor […]

More Information Supplier Page

CP-466722 5 mg  | 99.85%

TargetMol

CP-466722, an effective and reversible ATM inhibitor, does not inhibit ATR and PI3K or PIKK family members in cells.

More Information Supplier Page

Astragaloside A 50 mg  | 99.87%

TargetMol

Astragaloside A (Astragaloside IV) is the primary pure saponin isolated from Astragalus membranaceus, which has been widely used for the therapy of cardiovascular diseases.

More Information Supplier Page